Nonimmune hydrops fetalis diagnosed at 35 weeks gestation - a case report.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος:	Nonimmune hydrops fetalis diagnosed at 35 weeks gestation - a case report.
Συγγραφείς:	Anghelina L; Department of Medical Informatics and Biostatistics, University of Medicine and Pharmacy of Craiova, Romania; mircea_serbanescu@yahoo.com., Şerbănescu MS, Stănescu GL, Gheonea C, Stănescu MR, Siminel MA
Πηγή:	Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie [Rom J Morphol Embryol] 2024 Jul-Sep; Vol. 65 (3), pp. 537-541.
Τύπος έκδοσης:	Case Reports; Journal Article
Γλώσσα:	English
Στοιχεία περιοδικού:	Publisher: Editura Academiei Române Country of Publication: Romania NLM ID: 9112454 Publication Model: Print Cited Medium: Internet ISSN: 2066-8279 (Electronic) Linking ISSN: 12200522 NLM ISO Abbreviation: Rom J Morphol Embryol Subsets: MEDLINE
Imprint Name(s):	Original Publication: Bucuresti, România : Editura Academiei Române, [1990-
Ιατρικοί όροι (MeSH):	Hydrops Fetalis/diagnosis , Hydrops Fetalis/pathology, Humans ; Female ; Pregnancy ; Adult ; Gestational Age
Περίληψη:	Nonimmune hydrops fetalis (NIHF) is a condition that can occur at any stage of pregnancy and is linked to a variety of disorders, resulting in severe perinatal complications and increased mortality risk. NIHF refers specifically to cases where maternal antibodies against red blood cell antigens are excluded. Early identification of the underlying causes is essential for managing pregnancy and deciding on treatment. The prognosis depends on the causes, both in the short and long term. Each case should be considered individually. We describe a case of severe fetal hydrops first identified at 35 weeks of gestation. In this instance, a definitive diagnosis could not be reached during pregnancy. An accurate diagnosis combined with early prenatal detection of NIHF is vital for reducing neonatal mortality associated with this condition.
Competing Interests:	The authors declare that they have no conflict of interests.
References:	J Obstet Gynaecol Res. 2016 Apr;42(4):385-91. (PMID: 26712114) Am J Med Genet A. 2015 May;167A(5):1082-8. (PMID: 25712632) J Med Virol. 2008 Oct;80(10):1776-82. (PMID: 18712818) Am J Med Genet A. 2009 May;149A(5):844-51. (PMID: 19334091) Am J Obstet Gynecol. 1989 Feb;160(2):494-7. (PMID: 2916638) J Clin Med. 2022 Aug 26;11(17):. (PMID: 36078936) J Ultrasound Med. 2012 Feb;31(2):213-8. (PMID: 22298864) Orphanet J Rare Dis. 2012 Nov 08;7:86. (PMID: 23137060) Pediatr Dev Pathol. 1999 Sep-Oct;2(5):432-9. (PMID: 10441620) Am J Obstet Gynecol. 2015 Feb;212(2):127-39. (PMID: 25557883) Prenat Diagn. 2011 Feb;31(2):186-95. (PMID: 21268039) Reprod Sci. 2023 Sep;30(9):2805-2812. (PMID: 36988903) Clin Perinatol. 2000 Dec;27(4):1007-31. (PMID: 11816486) Obstet Gynecol Sci. 2020 Mar;63(2):108-116. (PMID: 32206649) Ultrasound Obstet Gynecol. 2020 Sep;56(3):416-421. (PMID: 32196790) World J Clin Cases. 2021 Aug 6;9(22):6531-6537. (PMID: 34435022) Cureus. 2021 Sep 8;13(9):e17830. (PMID: 34660039) Am J Med Genet A. 2012 Mar;158A(3):597-605. (PMID: 22302731) J Clin Med. 2020 Jun 08;9(6):. (PMID: 32521801) N Engl J Med. 2020 Oct 29;383(18):1746-1756. (PMID: 33027564) Clin Perinatol. 2020 Mar;47(1):105-121. (PMID: 32000919) Front Immunol. 2020 May 07;11:858. (PMID: 32457758) Obstet Gynecol Sci. 2015 Mar;58(2):90-7. (PMID: 25798421)
Contributed Indexing:	Keywords: causes; nonimmune hydrops fetalis; pregnancy outcome; prognosis
Entry Date(s):	Date Created: 20241112 Date Completed: 20241112 Latest Revision: 20250104
Update Code:	20260130
PubMed Central ID:	PMC11657371
DOI:	10.47162/RJME.65.3.17
PMID:	39529348
Βάση Δεδομένων:	MEDLINE

Full Text Finder

Περιγραφή
ISSN:	2066-8279
DOI:	10.47162/RJME.65.3.17